Pilot Study to Understand the Feasibility of Implementing a Wearable Device Cueing System Following Bone Marrow Transplant
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Blood Cancer
- Sponsor
- Medical College of Wisconsin
- Enrollment
- 15
- Locations
- 1
- Primary Endpoint
- Pilot evaluation of intervention efficacy
- Status
- Active, Not Recruiting
- Last Updated
- last year
Overview
Brief Summary
The purpose of this study is to pilot test the feasibility of providing patients diagnosed with a hematologic malignancy, undergoing an allogeneic bone marrow transplant, a wearable device and smartphone app (similar to a Fitbit), that would send personalized reminders to move during their post-transplant inpatient hospital stay to promote physical recovery and well-being.
Detailed Description
Enrolled patients who have been diagnosed with a hematologic malignancy and are scheduled to undergo an allogeneic bone marrow transplant will use a custom-designed wearable device and smartphone application as a behavioral intervention to cue exercise. Participants will be asked to wear the wearable device for the duration of their post-transplant inpatient hospital stay. Aim 1. To examine the potential efficacy of the wearable device + smartphone application to prompt alloBMT patients to move. Aim 2. To receive participant feedback on their experience participating in the study.
Investigators
Whitney Morelli
Principal Investigator
Medical College of Wisconsin
Eligibility Criteria
Inclusion Criteria
- •At least 18 years of age
- •Diagnosed with hematologic malignancy
- •Scheduled to receive an alloBMT
- •Physician consent to participate in the study
Exclusion Criteria
- •Inability to complete 15 minutes walking unassisted
Outcomes
Primary Outcomes
Pilot evaluation of intervention efficacy
Time Frame: cumulative percent from day 1 through discharge from hospital, on average day 30
Efficacy will be evaluated by examining the percentage of time participants responded to the cued exercise prompts.
Patient feedback from participation in the study
Time Frame: day 10
Patient experience will be evaluated by looking at the central tendencies of the ratings from the post-participation evaluation survey.